References
- Alberola V, Camps C, Sirera R, et al. (2006). Prognostic value of blood levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in advanced non-small cell lung cancer (NSCLC) patients. J Clin Oncol (Meeting Abstracts) 24:suppl 7196
- Bremnes RM, Camps C, Sirera R. (2006). Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 51:143–58
- Chen G, Wang M, Wang Y. (2005). Study on the expression and their relationship among P27, Bcl-2 and VEGF in lung cancer. ZhongguoFei Ai ZaZhi 8:207–10
- Daniel C, Albrecht H, Lüdke A, Hugo C. (2008). Nestin expression in repopulating mesangial cells promotes their proliferation. Lab Invest 88:387–97
- Gal A, Pentelenyi K, Remenyi V, et al. (2009). Bcl-2 or bcl-XL gene therapy increases neural plasticity proteins nestin and c-fos expression in PC12 cells. Neurochem Int 55:349–53
- Hlobilkova A, Ehrmann J, Knizetova P, et al. (2009). Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression. Neoplasma 56:284–90
- Huang YL, Wu CM, Shi GY, et al. (2009). Nestin serves as a prosurvival determinant that is linked to the cytoprotective effect of epidermal growth factor in rat vascular smooth muscle cells. J Biochem 146:307–15
- Jemal A, Siegel R, Ward E, et al. (2008). Cancer statistics. CA Cancer J Clin 58:71–96
- Kleeberger W, Bova GS, Nielsen ME, et al. (2007). Roles for the stem cell-associated intermediate filament nestin in prostate cancer migration and metastasis. Cancer Res 67:9199–206
- Krupkova O Jr, Loja T, Zambo I, Veselska R. (2010). Nestin expression in human tumors and tumor cell lines. Neoplasma 57:291–8
- Maciag A, Chakrapani H, Saavedra J, et al. (2011). The nitric oxide prodrug js-k is effective against non-small cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen species. J Pharmacol Exp Ther 336:313–20
- Mocellin S, Rossi CR, Pilati P, et al. (2003). Quantitative real-time PCR: a powerful ally in cancer research. Trends Mol Med 9:189–95
- Mokrý J, Nemecek S. (1999). Cerebral angiogenesis shows nestin expression in endothelial cells. Gen Physiol Biophys 18:25–9
- Mountain CF. (1997). Revisions in the international system for staging lung cancer. Chest 111:1710–17
- Qin Q, Sun Y, Fei M, et al. (2012). Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer. Neoplasma 59:310–15
- Ryuge S, Sato Y, Wang GQ, et al. (2011). Prognostic significance of nestin expression in resected non-small cell lung cancer. Chest 139:862–9
- Skarda J, Kolar Z, Janikova M, et al. (2012). Analysis of the prognostic impact of nestin expression in non-small cell lung cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 156:135–42
- Tas F, Duranyildiz D, Oguz H, et al. (2006). Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer. Cancer Invest 24:576–80
- Timotheadou E, Murray S, Linardou H, et al. (2005). VEGF165, Bcl-2, p53, COX-2 and HER-family expression in patients with stage IB-IIIA completely resected non-small cell lung cancer (NSCLC) and correlation with clinical outcome. J Clin Oncol (Meeting Abstracts) 23:suppl 7246
- Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC, eds. (2004). World Health Organization Classification of Tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart. Lyon: IARC Press
- Trisciuoglio D, Gabellini C, Desideri M, et al. (2011). Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells. Cell Death Differ Adv 18:1024–35
- Yamahatsu K, Matsuda Y, Ishiwata T, et al. (2012). Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis. Int J Oncol 40:1345–57